Clinical and Radiographic Evaluation of the Effect of Hyaluronic Acid Surface Treatment Versus Sandblasted Acid Etched on Stability of Delayed Dental Implant in Posterior Maxilla.

Launched by CAIRO UNIVERSITY · Sep 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for the surface of dental implants placed in the back of the upper jaw (posterior maxilla) for patients who have missing teeth and may have experienced some bone loss. The trial will compare the effectiveness of a treatment using hyaluronic acid—a substance that can help with healing and stability—against a more traditional method called sandblasted acid etching, which helps create a rough surface on the implant to promote better bonding with the bone.

To participate in this study, patients must be between 18 and 60 years old and have missing teeth in the back of their upper jaw. However, certain health conditions may prevent someone from being eligible, such as uncontrolled diabetes, untreated gum disease, or recent radiation treatment in the head and neck area. Participants can expect to undergo the dental implant procedure and will be monitored to see how well each type of implant treatment works over time. This trial is not yet recruiting participants, so there's still time to learn more before deciding to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with missing teeth in posterior maxilla.
• • Both genders males and females will be included.
• • Age from 18-60 years.
• Exclusion Criteria:
• • General contraindications to implant surgery.
• • Subjected to irradiation in the head and neck area less than 1 year before implantation.
• • Untreated periodontitis.
• • Poor oral hygiene and motivation.
• • Uncontrolled diabetes.
• • Pregnant or nursing.
• • Substance abuse.
• • Psychiatric problems or unrealistic expectations.
• • Severe bruxism or clenching.
• • Immunosuppressed or immunocompromised.
• • Treated or under treatment with intravenous amino-bisphosphonates.
• • Active infection or severe inflammation in the area intended for implant placement.
• • Unable to open mouth sufficiently to accommodate the surgical tooling.
• • Patients participating in other studies, if the present protocol could not be properly followed.